PCI Restores Approval for 42 Pharmacy Colleges in Maharashtra for 2025-26 Admissions
Mumbai: Weeks after barring admissions at nearly 90 pharmacy colleges, the Pharmacy Council of India (PCI) has now reinstated approval for 42 institutions across Maharashtra to admit students for B.Pharm and D.Pharm programmes in the academic year 2025-26.
The move follows a detailed compliance review by the Directorate of Technical Education (DTE) and court directives, marking a significant turnaround for several colleges earlier flagged for non-compliance.
The PCI’s latest decision covers 8 B.Pharm and 34 D.Pharm institutions that successfully rectified deficiencies related to faculty strength, infrastructure, and facilities. The Council’s 434th meeting examined the Maharashtra government’s letter dated September 29, 2025, and the Bombay High Court orders of September 24 and 26, before concluding that these institutes had met all regulatory requirements to resume admissions.
“Based on the latest information on record, including the Government of Maharashtra’s communication dated September 29, 2025, the Council decided to restore admission status of 42 colleges for the 2025–26 academic year,” the PCI stated in its circular.
The approved institutions include:
Mayani Bhag Shikshan Prasark Mandal’s College of Pharmacy – 60 seats
SBNM College of Pharmacy – 60 seats
Aldel College of Pharmacy & Research, St. John Technical & Education Campus – 100 seats
Dnyan Ganga College of Pharmacy – 60 seats
Jay Bharat College of Pharmacy – 60 (BPharm) + 60 (DPharm) seats
Brahma Valley Institute of Pharmacy – 60 seats
Late Devrao Digamber Varat College of Pharmacy – 60 seats
Balasaheb Desai College of Pharmacy – 60 seats
Alongside these, 34 DPharm colleges have also been cleared to admit students after meeting the PCI’s infrastructure and staffing standards. Some approvals were reinstated following favourable court rulings in response to petitions filed by the institutions.
Earlier, the PCI had withdrawn approval from 89 colleges, including 18 BPharm and 71 DPharm institutes, citing serious lapses in infrastructure, teaching staff, and documentation. The Council noted that several colleges subsequently submitted compliance evidence and successfully passed reinspection by the Maharashtra State Board of Technical Education (MSBTE) and the DTE, reports The Telegraph India.
The PCI has emphasized that all approved institutions must maintain academic standards, qualified faculty, and adequate infrastructure to retain recognition in future sessions. The decision is seen as an important balancing act between regulatory vigilance and continuity of education for thousands of pharmacy students in Maharashtra.
